Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients

Recent studies estimated an incidence of 4–25% of disease rebound after withdrawal of fingolimod (FTY) for any reason, but specific data on disease reactivation after FTY withdrawal due to pregnancy are limited. The aim of the study was to evaluate the frequency and predictors of disease reactivatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianco, Assunta, Lucchini, Matteo, Totaro, Rocco, Fantozzi, Roberta, De Luca, Giovanna, Di Lemme, Sonia, Presicce, Giorgia, Evangelista, Luana, Di Tommaso, Valeria, Pastorino, Roberta, De Fino, Chiara, De Arcangelis, Valeria, Centonze, Diego, Mirabella, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803993/
https://www.ncbi.nlm.nih.gov/pubmed/34494237
http://dx.doi.org/10.1007/s13311-021-01106-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803993/
https://www.ncbi.nlm.nih.gov/pubmed/34494237
http://dx.doi.org/10.1007/s13311-021-01106-6

Ejemplares similares